Background
Methods
SLC7A5 copy number and gene expression
Patients and tumours
Western blotting
Tissue arrays and immunohistochemical analysis
Statistical analysis
Results
SLC7A5 genomic profiling
SLC7A5 expression in breast cancer
SLC7A5 and clinicopathological parameters
SLC7A5 protein | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Discovery set | Validation set | |||||||||
Number (%) | Mean | p value | Adjusted p value | Number (%) | Mean | p value | Adjusted p value | |||
Patient’s age (years) | ||||||||||
≥50 | 395 (36) | 582.20 | 0.003 |
0.018
| 469 (30) | 859.46 | 7.0 × 10−12 |
<0.0001
| ||
<50 | 714 (64) | 539.95 | 1070 (70) | 730.79 | ||||||
Tumour size | ||||||||||
≥2.0 cm | 532 (48) | 521.22 | 0.000002 |
<0.0001
| 939 (61) | 729.47 | 6.5 × 10−9 |
<0.0001
| ||
˂2.0 cm | 577 (52) | 586.14 | 599 (39) | 832.24 | ||||||
Lympho-vascular invasion | ||||||||||
Negative | 722 (65) | 545.17 | 0.138 | 0.55 | 1086 (71) | 743.95 | 0.000007 |
<0.0001
| ||
Positive | 382 (35) | 566.35 | 451 (29) | 829.31 | ||||||
Site of distant metastasis | ||||||||||
Brain | ||||||||||
No | 1044 (94) | 546.62 | 0.0001 |
0.0008
| N/A | |||||
Yes | 61 (6) | 662.27 | ||||||||
Lung | ||||||||||
No | 1003 (91) | 547.12 | 0.007 |
0.04
| N/A | |||||
Yes | 102 (9) | 610.80 | ||||||||
Bone | ||||||||||
No | 876 (79) | 554.57 | 0.651 | 1.30 | N/A | |||||
Yes | 229 (21) | 547.00 | ||||||||
Liver | ||||||||||
No | 949 (86) | 551.43 | 0.568 | 1.70 | N/A | |||||
Yes | 156 (14) | 562.57 | ||||||||
Number (%) | Mean | χ2 | p value | Adjusted p value | Number (%) | Mean | χ2 | p value | Adjusted p value | |
Tumour grade | ||||||||||
1 | 190 (17) | 450.77 | 171.5 | 5.6 × 10−38 |
<0.0001
| 231 (15) | 585.30 | 723.48 | 7.7 × 10−72 |
<0.0001
|
2 | 366 (33) | 473.19 | 622 (40) | 647.46 | ||||||
3 | 550 (50) | 642.43 | 685 (45) | 942.43 | ||||||
Lymph node stage | ||||||||||
1 | 674 (61) | 542.19 | 4.811 | 0.09 | 0.45 | 955 (62) | 754.30 | 12.56 | 0.002 |
0.004
|
2 | 341 (31) | 574.98 | 428 (28) | 767.94 | ||||||
3 | 91 (8) | 556.75 | 153 (10) | 858.69 | ||||||
Nottingham Prognostic Index | ||||||||||
Good | 332 (30) | 458.21 | 102.4 | 5.6 × 10−23 |
<0.0001
| 521 (34) | 620.66 | 156.60 | 9.8 × 10−35 |
<0.0001
|
Moderate | 593 (53) | 578.27 | 768 (50) | 828.08 | ||||||
Poor | 184 (17) | 654.64 | 246 (16) | 892.49 | ||||||
IHC subtypes | ||||||||||
ER+/HER2- low proliferation | 250 (27) | 391.92 | 178.4 | 1.8 × 10−38 |
<0.0001
| N/A | ||||
ER+/HER2- high proliferation | 351 (38) | 419.54 | ||||||||
Triple negative | 191 (20) | 617.95 | ||||||||
HER2+ | 143 (15) | 519.69 | ||||||||
Histological type | ||||||||||
Ductal (including mixed) | 922 (83) | 563.83 | 69.05 | 3.5 × 10−14 |
<0.0001
| 1335 (87) | 782.19 | 77.07 | 7.2 × 10−16 |
<0.0001
|
Lobular | 101 (9) | 454.17 | 120 (8) | 584.17 | ||||||
Medullary | 26 (2) | 832.02 | 13 (0.8) | 1257.27 | ||||||
Miscellaneous | 7 (0.6) | 440.50 | 9 (0.6) | 1037.78 | ||||||
Special type | 53 (5.4) | 472.75 | 57 (3.6) | 655.12 |
SLC7A5 copy number
| ||||||||
---|---|---|---|---|---|---|---|---|
Gain | Loss | |||||||
No, number (%) | Yes, number (%) | χ2 (p value) | Adjusted p value | No, number (%) | Yes, number (%) | χ2 (p value) | Adjusted p value | |
Age (years) | ||||||||
≥50 | 1520 (97.7) | 36 (2.3) | 0.405 (0.524) | 1.572 | 1098 (70.6) | 458 (29.4) | 27.479 (1.5 × 10− 7) |
<0.0001
|
˂50 | 372 (97.1) | 11 (2.9) | 321 (83.8) | 62 (16.2) | ||||
Tumour size | ||||||||
≥2.0 cm | 1291 (97.0) | 40 (3.0) | 5.226 (0.022) | 0.132 | 976 (73.3) | 355 (26.7) | 0.094 (0.759) | 0.282 |
˂2.0 cm | 614 (98.7) | 8 (1.3) | 452 (72.7) | 170 (27.3) | ||||
Tumour grade | ||||||||
1 | 170 (100.0) | 0 (0.0) | 10.154 (0.006) |
0.042
| 99 (58.2) | 71 (41.8) | 107.36 4.8 × 10−24 |
<0.0001
|
2 | 756 (98.2) | 14 (1.8) | 495 (64.3) | 275 (35.7) | ||||
3 | 918 (96.4) | 34 (3.6) | 799 (83.9) | 153 (16.1) | ||||
Lymph node stage | ||||||||
1 | 1012 (97.8) | 23 (2.2) | 0.474 (0.789) | 1.578 | 726 (70.1) | 309 (29.9) | 10.425 (0.005) |
0.02
|
2 | 606 (97.4) | 16 (2.6) | 480 (77.2) | 142 (22.8) | ||||
3 | 307 (97.2) | 9 (2.8) | 237 (75.0) | 79 (25.0) | ||||
Nottingham Prognostic Index | ||||||||
Good | 668 (98.2) | 12 (1.8) | 2.602 (0.272) | 0.080 | 418 (61.5) | 262 (38.5) | 76.132 (2.9 × 10−17) |
<0.0001
|
Moderate | 1071 (97.3) | 30 (2.7) | 864 (78.5) | 237 (21.5) | ||||
Poor | 192 (96.5) | 7 (3.5) | 168 (84.4) | 31 (15.6) | ||||
Histological type | ||||||||
Ductal | 1500 (97.2) | 44 (2.8) | 6.880 (0.230) | 1.150 | 1154 (74.7) | 390 (25.3) | 29.544 (0.00001) |
0.0001
|
Lobular | 145 (98.6) | 2 (1.4) | 88 (59.9) | 59 (40.1) | ||||
Medullary | 30 (93.8) | 2 (6.3) | 30 (93.8) | 2 (6.2) | ||||
Miscellaneous | 12 (100.0) | 0 (0.0) | 9 (75.0) | 3 (25.0) | ||||
Special type | 113 (100.0) | 0 (0.0) | 74 (66.8) | 39 (33.2) | ||||
PAM50 subtype | ||||||||
Luminal A | 710 (98.9) | 8 (1.1) | 40.515 (3.3 × 10−8) |
<0.0001
| 423 (58.9) | 295 (41.1) | 248.3 (1.4 × 10−52) |
<0.0001
|
Luminal B | 477 (97.7) | 11 (2.3) | 312 (63.9) | 176 (36.1) | ||||
Basal | 305 (92.7) | 24 (7.3) | 319 (97.0) | 10 (3.0) | ||||
HER2+ | 235 (97.9) | 5 (2.1) | 219 (91.3) | 21 (8.7) | ||||
Normal-like | 198 (99.5) | 1 (0.5) | 172 (11.9) | 27 (5.1) | ||||
MYC gain | ||||||||
No | 1228 (98.9) | 14 (1.1) | 25.0 (5.5 × 10−7) |
<0.0001
| 1446 (73.3) | 528 (26.7) | 0.132 (0.716) | 1.432 |
Yes | 703 (95.3) | 35 (4.7) | 4 (66.7) | 2 (33.3) |
SLC7A5 expression in molecular BC subtypes
SLC7A5 protein | ||||||||
---|---|---|---|---|---|---|---|---|
Discovery set | Validation set | |||||||
Number (%) | Mean | p value | Adjusted p value | Number (%) | Mean | p value | Adjusted p value | |
ER | ||||||||
Negative | 270 (25) | 722.20 | 3.2 × 10−48 |
<0.0001
| 300 (19) | 1094.70 | 4.6 × 10−76 |
<0.0001
|
Positive | 827 (75) | 492.45 | 1240 (81) | 692.06 | ||||
PgR | ||||||||
Negative | 435 (41) | 619.12 | 8.8 × 10−27 |
<0.0001
| 612 (42) | 855.53 | 1.3 × 10−34 |
<0.0001
|
Positive | 630 (59) | 473.54 | 853 (58) | 645.09 | ||||
HER2 | ||||||||
Negative | 921 (87) | 521.78 | 0.00004 |
0.0001
| 1337 (92) | 718.53 | 0.001 |
0.002
|
Positive | 143 (13) | 601.54 | 116 (8) | 824.67 | ||||
Triple negative | ||||||||
No | 896 (83) | 503.50 | 4.5 × 10−35 |
<0.0001
| 1286 (83) | 696.76 | 1.5 × 10−62 |
<0.0001
|
Yes | 185 (17) | 722.61 | 225 (17) | 1094.6 | ||||
Basal phenotype | ||||||||
No | 794 (74) | 510.96 | 6.8 × 10−13 |
<0.0001
| N/A | |||
Yes | 285 (26) | 620.90 | ||||||
P53 protein | ||||||||
Negative | 760 (72) | 499.14 | 4.1 × 10−13 |
<0.0001
| N/A | |||
Positive | 298 (28) | 606.92 |
SLC7A5 mRNA expression | |||||
---|---|---|---|---|---|
Number (%) | Mean | t test | p value | Adjusted p value | |
Estrogen receptor | |||||
Negative | 474 (24) | 9.543 | 26.90 | 5.6 × 10− 113 |
<0.0001
|
Positive | 1506 (76) | 7.943 | |||
Progesterone receptor | |||||
Negative | 940 (47) | 8.862 | 18.73 | 1.07 × 10−71 |
<0.0001
|
Positive | 1040 (53) | 7.841 | |||
HER2 | |||||
Negative | 1733 (88) | 8.216 | −12.35 | 1.1 × 10−29 |
<0.0001
|
Positive | 247 (12) | 9.095 | |||
Triple negative (ER-, PR-, HER2-) | |||||
No | 1660 (84) | 8.065 | −22.12 | 1.9 × 10−73 |
<0.0001
|
Yes | 320 (16) | 9.676 | |||
Basal phenotype | |||||
No | 1645 (83) | 8.036 | −25.70 | 1.5 × 10−91 |
<0.0001
|
Yes | 329 (17) | 9.788 | |||
TP53 mutation | |||||
Wild-type | 721 (88) | 8.132 | −7.47 | 1.2 × 10−11 |
<0.0001
|
Mutation | 99 (12) | 9.148 |
SLC7A5 expression and other associated markers
SLC7A5 mRNA expression | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
All cases (n = 1980) | Luminal A (n = 368) | Luminal B (n = 367) | HER2+ (n = 110) | Triple negative (n = 150) | ||||||
Correlation Coefficient (p value) | Adjusted p value | |||||||||
Regulatory and other associated genes | ||||||||||
MYC | 0.133 (2.4 × 10−9) |
<0.0001
| 0.012 (0.752) | 4.145 | 0.155 (0.001) |
0.019
| 0.066 (0.310) | 4.650 | 0.103 (0.062) | 0.434 |
mTOR | 0.085 (0.0001) |
0.001
| −0.005 (0.904) | 1.824 | 0.088 (0.052) | 0.728 | −0.023 (0.723) | 5.784 | 0.067 (0.226) | 1.130 |
VEGFA | 0.352 (6.4 × 10−59) |
<0.0001
| 0.166 (0.000008) |
0.0002
| 0.260 (5.3 × 10−9) |
<0.0001
| 0.269 (0.00002) |
0.0005
| 0.244 (0.000008) |
0.0002
|
HIF2A | −0.050 (0.028) | 0.168 | −0.023 (0.536) | 4.896 | 0.215 (0.000002) |
<0.0001
| 0.112 (0.083) | 1.328 | −0.282 (1.8 × 10−7) |
<0.0001
|
ATF4 | 0.159 (1.0 × 10−12) |
<0.0001
| − 0.029 (0.433) | 5.100 | 0.057 (0.208) | 2.080 | 0.143 (0.026) | 0.468 | 0.108 (0.050) | 0.450 |
Glutamine-proline regulatory axis | ||||||||||
GLS | 0.048 (0.032) | 0.192 | 0.008 (0.829) | 3.428 | 0.055 (0.222) | 1.998 | −0.006 (0.927) | 4.635 | −0.115 (0.038) | 0.456 |
ALDH4A1 | −0.053 (0.019) | 0.133 | 0.018 (0.638) | 4.512 | 0.063 (0.163) | 1.793 | −0.028 (0.663) | 5.967 | −0.134 (0.015) | 0.225 |
PRODH | 0.004 (0.858) | 1.716 | −0.034 (0.369) | 4.763 | −0.032 (0.483) | 2.415 | 0.037 (0.573) | 5.73 | 0.030 (0.582) | 1.746 |
PYCR1 | 0.32 (1.5 × 10−50) |
<0.0001
| 0.143 (0.0001) |
0.001
| 0.253 (1.3 × 10−8) |
<0.0001
| 0.210 (0.001) |
0.024
| 0.303 (1.9 × 10−8) |
<0.0001
|
ALDH18A1 | 0.222 (1.6 × 10−23) |
<0.0001
| 0.151 (0.00004) |
0.0008
| 0.144 (0.001) |
0.018
| 0.168 (0.009) | 0.180 | 0.356 (2.9 × 10−11) |
<0.0001
|
GLUL | −0.18 (3.3 × 10−16) |
<0.0001
| 0.134 (0.0003) |
0.005
| 0.008 (0.863) | 1.726 | −0.001 (0.991) | 1.982 | −0.122 (0.028) | 0.392 |
GLUD1 | −0.38 (4.3 × 10−69) |
<0.0001
| − 0.161 (0.00001) |
0.0002
| − 0.237 (1.1 × 10−7) |
<0.0001
| −0.148 (0.022) | 0.418 | −0.112 (0.042) | 0.420 |
Glutamine/glutamate transporters | ||||||||||
SLC1A5 | 0.29 (4.5 × 10−41) |
<0.0001
| 0.170 (0.000005) |
0.0001
| 0.150 (0.001) |
0.017
| 0.208 (0.001) |
0.023
| 0.25 (0.000002) |
<0.0001
|
SLC3A2 | 0.17 (1.1 × 10−14) |
<0.0001
| 0.067 (0.072) | 3.780 | 0.193 (0.00001) |
0.0002
| 0.184 (0.004) | 0.084 | 0.158 (0.004) | 0.064 |
SLC6A19 | 0.004 (0.869) | 1.738 | 0.041 (0.273) | 4.428 | −0.008 (0.859) | 2.577 | 0.047 (0.473) | 5.676 | −0.103 (0.061) | 0.488 |
SLC7A6 | 0.362 (2.7 × 10−62) |
<0.0001
| 0.254 (5.3 × 10−12) |
<0.0001
| 0.33 (2.0 × 10− 14) |
<0.0001
| 0.284 (0.000008) |
0.0002
| 0.071 (0.201) | 1.206 |
SLC7A7 | 0.19 (4.6 × 10−19) |
<0.0001
| 0.007 (0.857) | 2.712 | 0.085 (0.061) | 0.793 | 0.041 (0.530) | 5.830 | −0.22 (0.00005) |
0.0001
|
SLC7A8 | −0.42 (1.1 × 10−88) |
<0.0001
| −0.115 (0.002) |
0.034
| −0.103 (0.022) | 0.352 | −0.203 (0.002) |
0.044
| −0.40 (3.9 × 10− 14) |
<0.0001
|
SLC7A9 | − 0.068 (0.002) | 0.01 | 0.025 (0.510) | 4.82 | 0.044 (0.333) | 2.331 | −0.123 (0.056) | 0.952 | 0.283 (1.8 × 10−7) |
<0.0001
|
SLC38A1 | −0.10 (0.000003) |
<0.0001
| −0.041 (0.270) | 3.549 | 0.039 (0.391) | 2.346 | 0.053 (0.413) | 5.369 | 0.113 (0.041) | 0.451 |
SLC38A2 | −0.055 (0.015) | 0.120 | −0.074 (0.048) | 1.05 | −0.103 (0.022) | 0.330 | 0.007 (0.917) | 5.502 | −0.119 (0.032) | 0.416 |
SLC38A3 | 0.18 (8.3 × 10−17) |
<0.0001
| 0.140 (0.0001) |
0.002
| 0.046 (0.311) | 2.488 | 0.003 (0.958) | 2.874 | 0.196 (0.0003) |
0.005
|
SLC38A5 | 0.011 (0.627) | 2.574 | −0.069 (0.066) | 1.08 | −0.077 (0.090) | 1.080 | −0.017 (0.793) | 5.551 | −0.017 (0.757) | 1.514 |
SLC38A7 | 0.306 (3.8 × 10−44) |
<0.0001
| 0.270 (2.0 × 10−13) |
<0.0001
| 0.32 (1.2 × 10−13) |
<0.0001
| 0.064 (0.324) | 4.536 | 0.177 (0.001) |
0.017
|
SLC38A8 | 0.023 (0.312) | 1.560 | −0.019 (0.612) | 4.466 | 0.011 (0.801) | 3.204 | −0.006 (0.930) | 3.720 | −0.039 (0.482) | 1.928 |
SLC7A5 protein | |||
---|---|---|---|
Biomarker | Correlation coefficient | p value | Adjusted p value |
c-MYC | 0.164 | 8.2 × 10−7 |
<0.0001
|
Ki67 | 0.311 | 1.1 × 10−21 |
<0.0001
|
P-mTORC1 | −0.150 | 0.00001 |
<0.0001
|
PIK3CA | 0.190 | 3.4 × 10−7 |
<0.0001
|
SLC1A5 | 0.331 | 1.1 × 10−25 |
<0.0001
|
GLUD1 | 0.053 | 0.09 | 0.180 |
GLS | 0.371 | 2.2 × 10−30 |
<0.0001
|
PYCR1 | 0.283 | 1.07 × 10−16 |
<0.0001
|
SLC7A5 expression and patient outcome
SLC7A5 protein | ||||||
---|---|---|---|---|---|---|
All cases | ER+ high proliferation | |||||
Parameter | Hazard ratio (95% CI) | p value | Adjusted p value | Hazard ratio (95% CI) | p value | Adjusted p value |
SLC7A5 | 1.001 (1.000–1.003) | 0.063 | 0.126 | 1.004 (1.001–1.006) | 0.006 |
0.024
|
Lymph node stage | 2.060 (1.813–2.341) | 1.7 × 10−28 |
<0.0001
| 1.756 (1.427–2.161) | 1.04 × 10−7 |
<0.0001
|
Size | 1.365 (1.111–1.678) | 0.003 |
0.009
| 1.169 (0.838–1.632) | 0.358 | 0.716 |
Grade | 2.454 (2.023–2.977) | 1.8 × 10−20 |
<0.0001
| 1.756 (1.154–2.672) | 0.009 |
0.027
|